<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16594">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01847209</url>
  </required_header>
  <id_info>
    <org_study_id>2012P001915</org_study_id>
    <nct_id>NCT01847209</nct_id>
  </id_info>
  <brief_title>Percutaneous Image Guided Video-Assisted Thoracic Surgery (VATS) Resection of Lung Lesions</brief_title>
  <official_title>Percutaneous Image Guided Video Assisted Thoracic Surgery (VATS) Resection of Lung Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Siemens Medical Solutions USA - CSG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a phase II protocol to determine the safety and feasibility of Intraoperative CT
      fluoroscopy guidance for lung resection for small nodules.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a phase II protocol to determine the safety and feasibility of image guided CT
      marking for resection of small lung nodules.  This is relevant because many such nodules are
      hard to localize for minimally invasive lung resection.  It is hoped that this technology
      using fluoro CT capability available now in most operating room will improve safety and
      reliability of thoracic surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The patient will be monitored while in the hospital by their thoracic surgical team as well as by two research nurses named Lauren Donahue, RN and Karen Magsipoc, NP. The research nurses will document any perioperative complications and mortality that arise during the patient's stay in the hospital.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Accurate and appropriate resection in a given timeline</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>CT Marking and VATS lung wedge resection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each patient with a lung nodule meeting criteria will undergo marking with fiducials followed at the same time by Video-Assisted Thoracic Surgery (VATS) lung wedge resection under CT fluoroscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Video-Assisted Thoracic Surgery (VATS) wedge resection</intervention_name>
    <arm_group_label>CT Marking and VATS lung wedge resection</arm_group_label>
    <other_name>Nodules marked with fiducials such as Kopan needles under CT fluoroscopy followed by VATS wedge resection.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  peripheral lung nodules &lt; 3cm in size

          -  Surgical candidate

        Exclusion Criteria:

          -  Non surgical candidate
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raphael Bueno, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raphael Bueno, MD</last_name>
    <phone>617 732 8148</phone>
    <email>rbueno@partners.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julianne Barlow</last_name>
    <phone>617 525 8541</phone>
    <email>jbarlow1@partners.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raphael Bueno, MD</last_name>
      <phone>617-732-8148</phone>
      <email>rbueno@partners.org</email>
    </contact>
    <contact_backup>
      <last_name>Ruth Swift</last_name>
      <phone>617 732 8148</phone>
      <email>rswift@partners.org</email>
    </contact_backup>
    <investigator>
      <last_name>Raphael Bueno, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raphael Bueno, MD</last_name>
      <phone>617-732-8148</phone>
      <email>rbueno@partners.org</email>
    </contact>
    <investigator>
      <last_name>Raphael Bueno, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 3, 2014</lastchanged_date>
  <firstreceived_date>May 2, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Raphael Bueno</investigator_full_name>
    <investigator_title>Associate Chief of Thoracic Surgery; Professor of Surgery</investigator_title>
  </responsible_party>
  <keyword>lung nodule</keyword>
  <keyword>lung cancer</keyword>
  <keyword>lung mass</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
